Cetera Investment Advisers
AVXL icon

Cetera Investment Advisers’s Anavex Life Sciences AVXL Stock Holding History

Cetera Investment Advisers’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$166K Buy
54,137
+11,281
+26% +$48.9K ﹤0.01% 4333
2025
Q4 		$153K Buy
42,856
+14,598
+52% +$89.4K ﹤0.01% 4296
2025
Q3 		$251K Buy
28,258
+12,436
+79% +$126K ﹤0.01% 3982
2025
Q2 		$146K Sell
15,822
-4,237
-21% -$36.2K ﹤0.01% 3808
2025
Q1 		$172K Buy
20,059
+6,058
+43% +$57.2K ﹤0.01% 3651
2024
Q4 		$150K Buy
+14,001
New +$108K ﹤0.01% 3504

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Cetera Investment Advisers's AVXL Position: Q1 2026 in Review

Cetera Investment Advisers increased its Anavex Life Sciences (AVXL) stake by 26% in Q1 2026, buying an estimated $48.9K and bringing the position to 54,137 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #4333.

Cetera Investment Advisers first reported a position in AVXL in Q4 2024 and has held it in 6 quarters since. The position peaked at $251K in Q3 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Cetera Investment Advisers held 54,137 shares of Anavex Life Sciences worth $166K as of Q1 2026.
  • Cetera Investment Advisers bought 11,281 Anavex Life Sciences shares in Q1 2026, an estimated $48.9K.
  • Anavex Life Sciences made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4333 holding.
  • Cetera Investment Advisers first reported a position in Anavex Life Sciences in Q4 2024 and has held it in 6 quarters since.
  • Cetera Investment Advisers's Anavex Life Sciences position peaked at $251K in Q3 2025.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.